Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Payment Experiments Coming To Medicare, Medicaid

Executive Summary

Centers For Medicare and Medicaid Services releases 'request for information' on how to approach development of new payment models for prescription drugs in government-sponsored insurance.

Advertisement

Related Content

HHS Leadership Upheaval Could Delay Initiatives Impacting Biopharma
Medicare Coding Change For Biosimilars Could Save $65bn, Firms Say
Novartis Begins CAR-T Payment Experiments With Outcomes-Based Contract With CMS
Policy People In The News: Patrick Conway Departs CMS
CMS Cancels Part B Demo Before HHS Secretary-Designate Price Does
Drug Use May Shift Under US Medicare Oncology Care Model; Here’s How

Topics

Related Companies

Related Deals

What to read next

Advertisement
UsernamePublicRestriction

Register

PS121599

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel